Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantum Santa Fe appears to be a private, patient-focused oncology clinical research organization and cancer center based in the Santa Fe, New Mexico area. Publicly available evidence indicates it has operated as an independent clinical trial site, with a focus on experimental therapeutics in cancer and some integrative medicine services. The organization has been associated with investigator-led and sponsor-funded oncology studies, including trials in metastatic bladder cancer, ovarian cancer, and other advanced solid tumors. Quantum Santa Fe is most visibly linked to founder and principal investigator Olivier Rixe (also cited as Oliver Rix in some sources), an academic oncologist previously affiliated with the University of New Mexico Comprehensive Cancer Center. It does not appear to be a drug developer with its own proprietary pipeline; rather, it functions as a clinical site/operator supporting external therapeutic programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantum Santa Fe.